SEC Form 4 · accession 0001209191-18-058508
bluebird bio, Inc. · BLUE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey T. Walsh
Officer — Chief Financial · Other
Period of report
Nov 9, 2018
Accepted (ET)
Nov 14, 2018 · 4:10 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001293971
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 9, 2018 | M | 1,500 | $24.47 | A | 36,995 | D | |
| Common StockF2 | Nov 9, 2018 | S | 320 | $129.1225 | D | 36,675 | D | |
| Common StockF3 | Nov 9, 2018 | S | 700 | $130.6129 | D | 35,975 | D | |
| Common StockF4 | Nov 9, 2018 | S | 480 | $131.5465 | D | 35,495 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F5 | $24.47 | Nov 9, 2018 | M | 1,500 | D | — | Mar 3, 2024 | Common Stock | 1,500 | 20,521 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 2, 2018.
- F2The range of prices for the transaction reported on this line was $128.90 to $129.61. The average weighted price was $129.1225. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3The range of prices for the transaction reported on this line was $130.10 to $131.06. The average weighted price was $130.6129. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F4The range of prices for the transaction reported on this line was $131.46 to $131.625. The average weighted price was $131.5465. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F5This option vested over a four-year period, at a rate of twenty-five percent (25%) on January 1, 2015 and in 36 equal monthly installments thereafter.